Fatos interessantes

• Merck CEO: Generic Singulair, uncertain economy to make 2012-13 difficult, but ... - Washington Post
  

  Merck CEO: Generic Singulair, uncertain economy to make 2012-13 difficult, but .

• Merck CEO: Generic Singulair, uncertain economy to make 2012-13 difficult, but ... - Washington Post
  

  Merck CEO: Generic Singulair, uncertain economy to make 2012-13 difficult, but .

• Merck Beats As Singulair Rakes In The Cash, But Patents Expire Soon - Forbes
  

  Kansas City StarMerck Beats As Singulair Rakes In The Cash, But Patents Expire SoonForbesMerck's first quarter earnings narrowly beat expectations, as the company continues to juice its blockbuster drug, Singulair.

• Merck CEO: Generics, economy to make 2012-13 tough - Newsday
  

  Merck CEO: Generics, economy to make 2012-13 toughNewsdaySpeaking at the company's annual meeting, Frazier noted the drugmaker's top seller, asthma and allergy drug Singulair, gets US generic competition soon.

• HealthWarehouse.com Offers Consumers the Lowest Price on Generic Plavix® - MarketWatch (press release)
  

  HealthWarehouse.